Read on Twitter
1/5 The CDC Advisory Committee on Immunization Practices (ACIP) met today and had an excellent session on #COVID19 vax development and prioritization. ACIP makes evidence-based recommendations on vaccine policy. Here are a few highlights and screen shots from the presentations.
2/5 The normal clinical development path will be accelerated without compromising standards. Operation Warp Speed supports rapid development of a few products, early scale-up of manufacturing, and harmonizing phase 3 trials. OWS needs to work closely with ACIP in coming months.
3/5 The ultimate goal is sufficient vaccine for entire US population, but initial supply will be limited. Planning is needed now to identify priority groups despite incomplete information. This process must be transparent, fair, and maximize benefits while minimizing harms.
4/5 The ACIP Covid19 Work Group presented guiding principles:
Safety will not be compromised.
Study participants should reflect at-risk populations.
Efficient and equitable vaccine distribution.
State & local public health must have flexibility to adapt to local needs.
Safety will not be compromised.Study participants should reflect at-risk populations.Efficient and equitable vaccine distribution.State & local public health must have flexibility to adapt to local needs.
5/5 As a first step, the ACIP work group proposed prioritizing critical healthcare/essential workers and people at risk for severe disease. Much feedback and discussion on specific risk groups. This process is just beginning and priority groups will be further refined.
